紫杉叶素市场：现况分析与预测（2023-2030）

由于健康和保健行业的成长，花旗松素市场预计将以约 6.1% 的复合年增长率强劲增长。 此外，由于不健康和久坐的生活方式导致发炎性疾病的增加，在增加紫杉醇市场需求方面发挥重要作用。 紫杉叶素具有抗发炎特性，抑制发炎分子的产生并促进健康的发炎反应。 例如，美国国立卫生研究院对花旗松素进行的一项研究发现，花旗松素透过调节参与氧化压力和发炎反应的多种物质，改善RAW264.7细胞遭受的发炎损伤，表明他有这种能力。 这表明花旗松素是治疗发炎性疾病进一步研究的有希望的候选者。 这项特性使花旗松素成为缓解关节炎、气喘和某些皮肤病等发炎性疾病相关症状的潜在有价值成分。

依纯度，市场分为<95%和>95%。 纯度低于95%的紫杉叶素占据最大的市场。 纯度低于 95% 的花旗松素受到青睐的主要因素之一是其成本效益。 较低纯度的花旗松素通常生产成本较低，这使得製造商更容易负担得起并吸引更大的客户群。 此外，花旗松素在医药、化妆品、食品和饮料等各行业都有应用。 对于某些应用，纯度较低的花旗松素就足够了，而不会影响产品品质或功效。 这种相容性使製造商能够透过提供纯度低于 95% 的花旗松素来满足市场需求，这足以满足许多应用的需要。

根据应用，市场分为食品和饮料、化妆品、医疗保健和农业。 食品和饮料产业是花旗松素市场的主要消费者之一。 推动食品和饮料产业对花旗松素需求的主要因素是消费者健康意识的不断增强，食品和饮料製造商正在加入花旗松素来提高其产品的营养价值。 此外，紫杉叶素的抗菌和抗发炎特性使其成为有效的天然防腐剂，可延长各种产品的保质期。 紫杉叶素已成为一种有价值的工具，可透过抑制引起腐败的微生物的生长来确保产品新鲜度并最大限度地减少浪费，这些因素正在推动食品和饮料行业对紫杉叶素的需求，并在扩张中发挥重要作用。

为更了解紫杉叶素的市场介绍，市场为北美（美国、加拿大等北美地区）、欧洲（德国、英国、法国、西班牙、义大利等欧洲地区）、亚太地区（中国、日本）、印度、世界其他地区（亚太地区）等世界其他地区。 亚太地区正成为花旗松素产品成长最快的市场之一。 推动紫杉醇产品高成长的主要因素之一是营养保健品产业的成长。 由于其潜在的健康益处，紫杉叶素被用作这些产品的活性成分，进一步增加了其需求。 此外，该地区心血管疾病、糖尿病和癌症等慢性疾病呈现上升趋势。 紫杉叶素对这些疾病的潜在预防作用鼓励其在功能性食品和饮料中的使用，吸引了越来越多的消费者群体。 此外，随着亚太地区许多国家可支配收入的增加，消费者有更多的购买力来投资优质健康产品。 花旗松素被定位为一种有益成分，正被纳入更高品质的产品中以适应这一趋势。

目录

第一章市场介绍

• 市场定义
• 主要目标
• 利害关係人
• 限制

第二章研究方法或假设

• 调查过程
• 调查方法
• 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对紫杉叶素市场的影响

第 6 章 紫杉叶素市场收入，2020-2030F。

第 7 章 Purity 的市场洞察

• 低于 95%
• 95% 或以上

第 8 章按应用划分的市场洞察

• 食品和饮料
• 化妆品
• 医疗保健
• 农业

第 9 章按地区划分的市场洞察

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国。
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 世界其他地区

第 10 章紫杉醇市场动态

• 市场驱动因素
• 市场挑战
• 影响分析

第十一章紫杉醇市场机会

第十二章紫杉醇市场趋势

第十三章需求方与供给方分析

• 需求方分析
• 供给面分析

第14章价值链分析

第15章竞争场景

• 竞争状况
  • 波特五力分析

第十六章公司简介

• Ametis JSC
• JW Health Products Pty Ltd
• Cayman Chemical
• Ebrator Biochemicals
• Adooq Bioscience LLC.
• Creative Enzymes.
• BOC Sciences
• Nature Science Technologies
• Alfa Chemistry
• United States Biological

第十七章免责声明

Taxilfolin, also known as TFX or Taxilfolin Extract, is a natural compound derived from a specific plant species known as Taxilfolia Vulgaris, which is predominantly found in the eastern Laos region. Taxilfolin is primarily popular for its potent antioxidant properties, which enable it to neutralize harmful free radicals within the body. This antioxidant activity aids in preventing cellular damage, reducing oxidative stress, and maintaining overall cellular health. Consequently, taxilfolin is thought to contribute to the prevention and management of various chronic diseases.

The Taxifolin Market is expected to grow at a strong CAGR of around 6.1% owing to the growing health and wellness industry. Furthermore, rising inflammatory diseases among the population due to unhealthy and sedentary lifestyles are playing a pivotal role in the growing demand for taxifolin in the market. Taxilfolin exhibits anti-inflammatory effects, inhibiting the production of pro-inflammatory molecules and promoting a healthy inflammatory response. For instance, the study done on taxifolin by the National Institutes of Health suggests that taxifolin possesses the ability to improve the inflammatory damage inflicted upon RAW264.7 cells by regulating various agents involved in oxidative stress and inflammatory reactions. This indicates that taxifolin holds immense promise for further investigation in the realm of treating inflammatory disorders. This characteristic makes taxifolin a potentially valuable component in alleviating symptoms associated with inflammatory conditions such as arthritis, asthma, and certain skin conditions.

Based on purity, the market is bifurcated into less than 95% and greater than equal to 95%. Taxifolin with purity less than 95% dominates the market with the largest share. One of the primary factors driving the dominance of taxifolin with a purity of less than 95% is its cost-effectiveness. Lower purity forms of taxifolin are generally cheaper to produce, making them more affordable for manufacturers, and attracting a larger customer base. Furthermore, Taxifolin finds applications in various industries, including pharmaceuticals, cosmetics, and food and beverages. For several applications, taxifolin with lower purity can suffice without compromising product quality or efficacy. This compatibility enables manufacturers to meet market demands by providing taxifolin with purity levels below 95%, which is sufficient for many applications.

Based on application, the market is segmented into foods and beverages, cosmetics, healthcare, and agriculture. The food and beverages industry is one of the predominant consumers of the taxifolin in the market. The primary factor that is driving the high demand for taxifolin in the food and beverages industry is the growing consumer demand for healthier food options, pushing food and beverage manufacturers to increasingly incorporate taxifolin to enhance the nutritional value of their products. Furthermore, Taxifolin's antimicrobial and anti-inflammatory properties have made it an effective natural preservative, aiding in extending the shelf life of various products. By inhibiting the growth of spoilage-causing microorganisms, taxifolin has emerged as a valuable tool for ensuring product freshness and minimizing waste, factors like these have played a vital role in the growing demand for taxifolin in the foods and beverages industry.

For a better understanding of the market adoption of taxifolin, the market is analyzed based on its worldwide presence in countries such as North America (The U.S., Canada, and the Rest of North America), Europe (Germany, The U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is emerging as one of the fastest-growing markets for taxifolin products. One of the primary factors that is driving the high growth of taxifolin products is the growing nutraceutical and dietary supplements industry. Taxifolin is being used as an active ingredient in these products due to its potential health benefits, further driving up the demand. Furthermore, the region has observed an increase in chronic diseases such as cardiovascular diseases, diabetes, and cancer. Taxifolin's potential protective effects against these conditions have prompted its usage in functional foods and beverages, attracting a growing consumer base. Additionally, as disposable incomes rise in many countries across the Asia Pacific, consumers have more purchasing power to invest in premium health products. Taxifolin, positioned as a beneficial ingredient, is being incorporated into higher-quality products to cater to this trend.

Some of the major players operating in the market include Ametis JSC; JW Health Products Pty Ltd; Cayman Chemical; Ebrator Biochemicals; Adooq Bioscience LLC.; Creative Enzymes.; BOC Sciences; Nature Science Technologies; Alfa Chemistry; and United States Biological

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Taxifolin Market
• 2.2. Research Methodology of the Taxifolin Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE TAXIFOLIN MARKET

6 TAXIFOLIN MARKET REVENUE (USD BN), 2020-2030F.

7 MARKET INSIGHTS BY PURITY

• 7.1. Less than 95%
• 7.2. Greater than equal to 95%

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Food and Beverages
• 8.2. Cosmetics
• 8.3. Healthcare
• 8.4. Agriculture

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. The U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. The U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. India
  • 9.3.3. Japan
  • 9.3.4. South Korea
  • 9.3.5. Rest of Asia-Pacific
• 9.4. Rest of the World

10 TAXIFOLIN MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 TAXIFOLIN MARKET OPPORTUNITIES

12 TAXIFOLIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Ametis JSC
• 16.2. JW Health Products Pty Ltd
• 16.3. Cayman Chemical
• 16.4. Ebrator Biochemicals
• 16.5. Adooq Bioscience LLC.
• 16.6. Creative Enzymes.
• 16.7. BOC Sciences
• 16.8. Nature Science Technologies
• 16.9. Alfa Chemistry
• 16.10. United States Biological

17 DISCLAIMER